Asia-Pacific Bio Preservation Market, By Product (Bio Preservation Media, Bio Preservation Equipment, Freezers, Cryogenic Storage Systems, Thawing Equipment, Refrigerators), Biospecimen (Human Tissue Samples, Organs, Stem Cells, Other Biospecimens), Application (Therapeutic Applications, Research Applications, Clinical Trials, Other Applications), End User (Biobanks, Gene Banks, Hospitals, Other End Users) – Industry Trends and Forecast to 2030.
Asia-Pacific Bio Preservation Market Analysis and Size
Biopreservation is witnessing huge growth because of the factors such as wide usage in hospitals and labs. Recently, there has been a rise in demand for the use of biopreservation for the development of biological products that are used in numerous sectors, such as vaccine production and immunotherapies. It is witnessed that regenerative medicine is anticipated to hold a huge market share during the forecast period, and several partnerships in this region are investing in regenerative medicine, improving the market size.
Data Bridge Market Research analyses a growth rate in the bio preservation market in the forecast period 2023-2030. The expected CAGR of bio preservation market tends to be around 10.50% in the mentioned forecast period. The market was valued at USD 0.71 billion in 2022 and will grow to USD 1.6 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Asia-Pacific Bio Preservation Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Bio Preservation Media, Bio Preservation Equipment, Freezers, Cryogenic Storage Systems, Thawing Equipment, Refrigerators), Biospecimen (Human Tissue Samples, Organs, Stem Cells, Other Biospecimens), Application (Therapeutic Applications, Research Applications, Clinical Trials, Other Applications), End User (Biobanks, Gene Banks, Hospitals, Other End Users)
|
|
Countries Covered
|
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)
|
|
Market Players Covered
|
Thermo Fisher Scientific (U.S.), Merck KGaA (U.S.)., LabVantage Solutions Inc (U.S.)., Taylor-Wharton (U.S.), Panasonic Holdings Corporation (Japan), QIAGEN (Germany), VWR International, LLC (U.S.), Teva Pharmaceutical Industries Ltd (Israel), X-Therma, Inc.(U.S.), PrincetonCryo (U.S.), BioLife Solutions Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Bio preservation is a process that supports storing biological samples for a prolonged period. Cells, tissues, and plasmas are some of the common samples that are preserved with the help of bio preservation. Biopreservation exploits the antimicrobial activities of some microorganisms to limit the growth of spoilage and pathogenic microbes in foods. The most widely used bio-preservatives are essential oils, bacteriocins, herbs and spices, fermentation, vinegar, and sugar and salt.
Asia-Pacific Bio Preservation Market Dynamics
Drivers
- Increasing Healthcare Expenditure Associated with Bio Preservatives
The increase in funding by several major companies to support bio-preservation-based pharmaceutical companies to satisfy the increasing demand for tissue and cell preservation is likely to boost the market growth. For instance, X-Therma Inc., a biotechnology start-up creating technology for regenerative medicine and organ preservation, closed an oversubscribed USD 13 million Series A funding round in 2021. Thus, this factor increases the growth of the market.
- Growing Partnerships between Companies Dealing with Bio Preservation
Numerous partnerships in this region in regenerative medicine boost research and development and are expected to increase the segment's growth. For instance, the Regenerative Medicine Catalyst Project was launched in collaboration with seven partners in 2021 to observe regenerative medicine research development and funding in the country in the upcoming three years. The increased demand for regenerative medicine that employs bio preservation to treat life-threatening diseases such as cancer will likely boost the market's growth.
Opportunities
- Increasing Product Launches Related to Bio Preservation
Several technological advancements, and growing product approvals by major market players, are helping the market growth. For instance, Guy's and St Thomas', U.K., launched a fertility preservation service for ovarian tissue cryopreservation for women who underwent cancer treatment in 2022. These increasing technological advancements and launches in bio preservation, combined with the cost-effectiveness of these instruments, is anticipated to create growth opportunities for the market. Thus, this factor boosts market growth.
- Rising Awareness About Bio Banking
People and healthcare researchers are becoming more aware and interested in biobanking each decade. Increasing awareness associated with stem cell preservation, rising acceptance of sperm and egg banking, and wide utilization of assistant reproductive technology in animals are boosting the growth of the market. Pharmaceutical companies are making huge collaborations with reserve bio-banks and hospitals for tissue preservation, boosting the market's growth.
Restraints/Challenges
- High Cost of Instruments
The increasing cost of the instruments and maintenance will likely restrict the market growth. Several technologies and methods, such as high-throughput screening, NGS, and many others, are quite costly and thus are unavailable in many research institutes and hospitals. This factor will delay the treatment process. Thus, all these factors hamper the growth of the market.
This bio preservation market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bio preservation market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In 2022, Azenta, Inc. acquired B Medical Systems S.á r.l, a provider of temperature-controlled storage and transportation solutions that allows the delivery of life-saving treatments globally.
- In 2022, Cellutions BioStorage, a research-to-launch Cryopreservation Bank, was launched in Chennai, India. Cellutions BioStorage is a full-service biomaterial storage and logistics provider that works with biopharmaceutical firms looking to outsource all aspects of supply chain management throughout a product's life cycle.
Asia-Pacific Bio Preservation Market Scope
The bio preservation market is segmented on the basis of product, biospecimens, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Bio preservation Media
- Bio preservation Equipment
- Freezers
- Cryogenic Storage Systems
- Thawing Equipment, Refrigerators
Biospecimen
- Human Tissue Samples
- Organs
- Stem Cells
- Other Biospecimens
Application
- Therapeutic Applications
- Research Applications
- Clinical Trials
- Other Applications
End User
- Biobanks
- Gene Banks
- Hospitals
- Other End Users
Bio Preservation Market Regional Analysis/Insights
The bio preservation market is analyzed, and market size insights and trends are provided by product, biospecimens, application, and end-user as referenced above.
The major countries covered in the bio preservation market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
China is expected to have the highest growth rate in the forecast period due to the huge technological advancements in the region. Also, the increasing demand for advanced devices and the rising funding support for techniques and services in bio-banking is helping the market's growth.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The bio preservation market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for bio preservation market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the bio preservation market. The data is available for historic period 2011-2021.
Competitive Landscape and Asia-Pacific Bio Preservation Market Share Analysis
The bio preservation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to bio preservation market
Key players operating in the bio preservation market include:
- Thermo Fisher Scientific (U.S.)
- Merck KGaA (U.S.)
- LabVantage Solutions Inc (U.S.)
- Taylor-Wharton (U.S.)
- Panasonic Holdings Corporation (Japan)
- QIAGEN (Germany)
- VWR International, LLC (U.S.)
- Teva Pharmaceutical Industries Ltd (Israel)
- X-Therma, Inc.(U.S.)
- PrincetonCryo (U.S.)
- BioLife Solutions Inc. (U.S.)
SKU-